Report from the 2011 Annual General Meeting in Aerocrine AB

Report from the 2011 Annual General Meeting in Aerocrine AB

The Annual General Meeting in Aerocrine was held on Thursday, May 5,
2011, in Stockholm

Anders Williamsson, Scott A. Beardsley, Lars Gustafsson, Staffan
Lindstrand, Yvonne Mårtensson and Karl Swartling was re-elected as Board
members. Dennis Kane and Rolf Klasson was elected as new Board members.
Anders Williamsson was re-elected as Chairman of the Board.
The parent company's and the group's income statements and balance
sheets were adopted. It was resolved that no dividend shall be paid and
that the year's loss shall be carried forward.
The Meeting resolved that the Nomination Committee for the Annual
General Meeting 2012 shall consist of representatives from the four
largest shareholders by voting powers (grouped by owner) and the
Chairman of the Board, whom shall also convene the Nomination Committee
for its first meeting. The composition of the Nomination Committee shall
be based on the share register maintained by Euroclear Sweden AB as per
August 31, 2011 and be published immediately following the appointment
of the Nomination Committee, however by no later than six months prior
to the Annual General Meeting.

The Meeting resolved to approve the Board's proposal to amend the
Articles of Association, to the effect that the share capital limits be
changed to not less than SEK 50,000,000 and not more than SEK
200,000,000, and the limits relating to the number of shares be changed
to not less than 100,000,000 and not more than 400,000,000 shares.

The Meeting resolved to approve the Board's proposal to authorize the
Board to resolve - at one or several occasions and for the time period
until the next Annual General Meeting - to increase the company's share
capital by new share issues and to issue warrants and convertible bonds,
to the extent that it corresponds to a dilution of not more than 10
percent of the number of shares outstanding at the date of the notice to
the 2011 Annual General Meeting, after full exercise of the
authorization. New share issues, as well as issues of warrants and
convertible bonds, may be made with or without deviation from the
shareholders' preferential rights and with or without provisions for
contribution in kind, set-off or other conditions.

For full information on each proposal approved by the Meeting, see
www.aerocrine.se (http://www.aerocrine.se/) where documentation relating
to the Meeting is available for download.

For further information, please contact:

Paul de Potocki, CEO, phone +46 (0)8 629 07 80